Original language | English |
---|---|
Pages (from-to) | 12068-12069 |
Journal | Blood |
Volume | 140 |
Issue number | Supplement 1 |
DOIs | |
Publication status | Published - Nov 2022 |
Externally published | Yes |
Trial in Progress: A Phase 1b/2 Study of GB5121, a Brain-Penetrant, Potent, Highly Selective, and Irreversible BTK Inhibitor for Relapsed/Refractory Primary/Secondary CNS Lymphoma and Primary Vitreoretinal Lymphoma
Carole Soussain, Samar Issa, Katharine L Lewis, Christian Grommes, Judith Fox, Renee Ward, Caryn Peterson, Matt Cravets, Anita Mathias, Judith Sosa, Brian J Kirby, Zhaoqing Ding, Isharat Yusuf, Mark J Rose, Marcos W Steinberg, Han W. Tun
Research output: Contribution to journal › Article › peer-review
1
Citation
(Web of Science)